what does crypto do, Top

Mercedes-Benz Group Co., Ltd. announced the personnel changes of the board of directors, and the Board of Supervisors of Mercedes-Benz Group Co., Ltd. decided the personnel changes of the board of directors. In 2025, Hubertus Troska, Sabine Kohleisen and Renata Jungo Brüngger, members of the board of directors of Mercedes-Benz Group, will retire after the contract expires. At the same time, the Board of Supervisors decided to appoint Oliver Thöne, Mathias Geisen and Olaf Schick as new board members.China Automotive Power Battery Industry Innovation Alliance: In November, the sales volume of power batteries in China increased by 29.7% year-on-year. According to the monthly information of power batteries in November 2024 released by China Automotive Power Battery Industry Innovation Alliance, the sales volume of power batteries and other batteries in China was 118.3GWh in November, up by 7.2% month-on-month and 40.1% year-on-year. Among them, the sales volume of power batteries was 87.8GWh, accounting for 74.2% of the total sales volume, up 10.9% from the previous month and 29.7% from the same period last year. The sales volume of other batteries was 30.5GWh, accounting for 25.8% of the total sales volume, down 2.2% from the previous month and up 82.3% year-on-year. From January to November, the cumulative sales volume of power and other batteries in China was 914.3GWh, a cumulative year-on-year increase of 42.8%. Among them, the cumulative sales of power batteries was 692.3GWh, accounting for 75.7% of the total sales, with a cumulative year-on-year increase of 27.1%; The cumulative sales volume of other batteries was 222.0GWh, accounting for 24.3% of the total sales volume, with a cumulative year-on-year increase of 132.5%.During the year, there were 461 new indices, and the index investment fever continued to climb. On December 10th, in order to meet the investment demand of diversified indices, CSI Index Co., Ltd. officially released five new indices, including CSI 1000 Growth Index, CSI 1000 Value Index, CSI 2000 Growth Index, CSI 2000 Value Index and CSI 1000 Quality Balance Strategy Index. With the "listing" of the above five indexes, the number of newly-issued indexes reached 461 during the year, covering categories such as strategy, style, scale, industry, theme and other fixed-income indexes; Related index asset classes include stocks, fixed income, funds and futures. At the same time, the secondary market, this year, the heat of indexed investment is also high. Looking forward to the future, with the continuous vigorous growth of market demand and unabated heat, and the precise guidance and strong support from the supervisory level, the indexed investment ecology will become more and more perfect. (Securities Daily)

ZTE signed a strategic cooperation agreement with Daiyu and Midea Group. Recently, ZTE signed a strategic cooperation agreement with Daiyu and Midea Group in Chengdu. In the future, the two sides will carry out in-depth cooperation in VR space, AR application and MR interaction.Jin Guanping, Economic Daily: Implement more active and promising macro policies. The article points out that the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on December 9 to analyze and study the economic work in 2025, and put forward "implement more active and promising macro policies" and "strengthen unconventional countercyclical adjustment" in view of the macro policy orientation next year, and clearly implement more active fiscal policies and moderately loose monetary policies. This important deployment has released a clear signal of strengthening macro-control and strong and steady growth. Implementing a "more active" fiscal policy means increasing fiscal countercyclical adjustment and improving the effectiveness of fiscal policy while maintaining policy stability and continuity. "Moderately loose" means that monetary policy will better reflect the supportive stance and orientation, maintain a reasonable and sufficient liquidity, and further reduce the comprehensive financing costs of enterprises and residents.Australia's S&P/ASX200 index opened down 12.60 points, or 0.15%, at 8380.4 points on Wednesday, December 11th.

The General Administration of Market Supervision held an anti-monopoly compliance lecture hall for the automobile industry. On December 11th, the General Administration of Market Supervision held the ninth anti-monopoly compliance lecture hall in Beijing to give lectures on anti-monopoly compliance for the automobile industry. The General Administration of Market Supervision requires the business entities of the automobile industry to compact the responsibility of the anti-monopoly compliance subject, actively regulate business practices, establish and improve the anti-monopoly compliance system, and effectively prevent and stop the occurrence of monopoly behaviors. The General Administration of Market Supervision will continue to pay attention to the competition in the automobile industry, further promote the special anti-monopoly law enforcement actions in the field of people's livelihood, promote the formation of a fairer and more dynamic market environment, and continuously enhance the people's sense of acquisition, happiness and security. (City speaks Newspeak)ZTE and ZTE Xinyun jointly released a digital intelligence financial solution. Recently, ZTE and ZTE Xinyun Cloud Service Co., Ltd. (referred to as "ZTE Xinyun") jointly released a digital intelligence financial solution based on digital nebula. The solution provides one-stop financial cloud application, fully supports financial functions and financial processes, solves breakpoints and pain points in the interaction between industry and finance, breaks the "data island" between systems, realizes the intelligent and efficient collection of business data and financial processing, and empowers the intelligent transformation of enterprise financial data.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.